by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Neuroimaging
ABSTRACT Background and Purpose 99mTc-TRODAT-1 SPECT imaging is an imaging technique, more commonly used in Asia, to diagnose Parkinson’s disease (PD). This study evaluates the use of automated three-dimensional volume-of-interest (VOI) analysis in diagnosing...
by Clinical Neuropsychologist | Wednesday, March 19, 2025 | Neuroimaging
ABSTRACT Background and Purpose Extensive research has been carried out to investigate changes in various gray matter (GM) regions during the aging process using resting-state functional MRI. However, the impact of aging on the functional connectivity (FC) between...
by Clinical Neuropsychologist | Wednesday, March 19, 2025 | Neuroimaging
ABSTRACT Background and Purpose Cladribine, an FDA-approved disease-modifying immunotherapy for multiple sclerosis (MS), penetrates the CSF and mitigates T cells and B cells, and thus may impact the development of cortical gray matter lesions (CLs) and leptomeningeal...
by Clinical Neuropsychologist | Monday, March 17, 2025 | Neuroimaging
ABSTRACT Intracranial aneurysms, with an annual incidence of 2%–3%, reflect a rare disease associated with significant mortality and morbidity risks when ruptured. Early detection, risk stratification of high-risk subgroups, and prediction of patient outcomes are...
by Clinical Neuropsychologist | Monday, March 17, 2025 | Neuroimaging
ABSTRACT Background and Purpose Intraarterial thrombolysis (IAT) has been sporadically used as an adjunct to mechanical thrombectomy (MT) in acute ischemic stroke patients for nearly two decades to improve distal arterial and microvascular perfusion even in patients...
by Clinical Neuropsychologist | Saturday, March 15, 2025 | Neuroimaging
ABSTRACT Background Alzheimer’s disease (AD) is a leading cause of dementia. Arterial spin labeling (ASL) MRI, particularly at 3 Tesla (3T), offers a noninvasive method to assess cerebral blood flow alterations, which are believed to be early indicators of AD....
